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BIOTECHNOLOGY IN THE DEVELOPMENT OF IMPROVED PHYTASES 
 
ROBERT E. SPEIGHT1 
 
Summary 
 
Phytase enzyme supplements are now ubiquitous in the commercial production of a range of 
livestock, particularly chickens and pigs. Significant effort has been directed over the last two 
decades towards producing improved enzymes with higher activity, increased stability and at 
economic levels in industrial fermentations. As such, there are excellent products on the 
market, but there is a continuing demand for further improvements to drive down costs and 
for enzyme manufacturers to increase market share. The rapid development of DNA 
sequencing and gene synthesis technologies has provided ready access to a large number of 
new and uncharacterised potential phytases. Challenges remain however in identifying and 
developing those with improved properties. 
 
I. INTRODUCTION 
 
Phosphate is essential for life and all organisms must have access to sufficient phosphate to 
survive and grow. Phytases are now routinely added to livestock feed for the removal of 
phosphate from the plant molecule phytate. Use of phytase reduces the addition of inorganic 
phosphate to diets and decreases the anti-nutritional effects of phytate. Phytase enzymes 
perform a variety of roles in nature in a variety of host organisms. For example, phytate is 
observed at high levels in seeds, typically at around 70-80% of total phosphorous in maize, 
wheat, sorghum and barley (Kornegay 2001, Selle et al. 2003). Phytase is present in these 
seeds to release phosphate and other nutrients bound to phytate, such as iron and zinc 
(Brinch-Pedersen et al. 2002) for plant growth. Microorganisms also produce phytases to 
access phosphate from phytate in environments where plant matter is present, including the 
gut and the soil (Pandey et al. 2001). Thus, nature provides a whole host of candidate 
phytases from a range of organisms that could be exploited as livestock feed supplements. 
Phytases have been identified in the past using traditional microbiology and biochemical 
approaches either from the environment or from culture collections (Pandey et al. 2001). The 
number of different candidates that can be accessed readily has increased dramatically in 
recent years due to the generation of vast amounts of genomic sequence data. With the 
continuing demand for ever-improved phytases coupled with competition for market share 
through best-in-class products, generating the most efficient methods for identifying and 
improving the best candidates for future economic large scale production is a constant 
endeavour. 
The three main characteristics that define the best phytase enzyme supplements are 
high specific activity in the gut, high stability and high levels of production in industrial 
microbial fermentations. Ultimately, the most important factor is optimising the amount of 
enzyme catalytic activity that can be realised in the animal gut, therefore releasing the 
optimal amount of phosphate for the desired animal growth rate and feed conversion 
efficiency at an appropriate financial cost. The higher the specific activity of the enzyme, the 
less mass of enzyme is needed to realise the same catalytic activity and so the enzyme 
loading (by mass) can be lower, saving on manufacturing cost. The yield (g/L) and 
volumetric productivity (g/L/day) of enzyme in an industrial fermentation can be optimised 
through recombinant microbial strain development and bioprocess engineering but will reach 
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an upper limit. As such, to fully optimise the number of units of enzyme activity that can be 
realised from an industrial fermentation, the enzyme should also display a high specific 
activity (U/g, where 1 unit (U) is defined as the conversion of 1 micromole of substrate per 
minute under specified assay conditions).  
Once an enzyme has been manufactured and formulated, as much of the original 
enzymatic activity should be realised in the gut of the animal as possible. Activity can be lost 
through thermal denaturation during feed pellet production, where the enzyme may be 
exposed to temperatures of up to 95 ºC, during storage and transportation and through 
degradation by proteases and the acidic conditions encountered in the gut. Further, the 
enzyme should display high levels of activity at gut pH (and in the most relevant part of the 
gut with the pH changing throughout the digestive system) and gut temperature (around 
37 ºC). The requirement for stability at high temperatures during pelleting coupled with 
optimal activity at the lower temperatures in the gut presents a major challenge as the 
molecular basis for increased thermal stability (such as increased structural rigidity) typically 
leads to a higher optimal temperature of activity (Giver et al. 1998). This phenomenon is 
often observed in enzymes from thermophilic organisms that are stable at very high 
temperatures but have relatively low or non-existent activities at gut temperature. In fact, due 
to reaction rates increasing with temperature generally and to achieve a compromise between 
activity and stability, many enzymes have optimal activities above gut temperature (Yao et al. 
2012). Ultimately, regardless of the temperature activity profile, it is the number of units of 
enzyme (specific activity) in gut conditions (temperature and pH) that is important. This 
paper will review and discuss methods to identify and develop improved phytase enzymes for 
animal feed applications. 
 
II. NEW ENZYME DISCOVERY 
 
In order to discover and develop enzymes with desired characteristics a number of 
approaches are commonly employed. In the first instance, the enzymes that naturally display 
the best possible characteristics should be identified from nature, using environmental 
sampling and/or genomic/protein databases. The better these ‘wild-type’ or native enzymes 
are the more likely protein engineering, if required, will deliver a suitable livestock feed 
supplement. Nature provides a very large number of organisms or putative gene/protein 
sequences in databases that could be screened. Traditional approaches have relied on the 
direct identification and characterisation of phytases from organisms of interest, including 
during basic studies into phosphate metabolism in organisms such as Saccharomyces 
cerevisiae (Oshima 1997) and for elucidating enzyme function in commonly used organisms 
such as Escherichia coli (Greiner et al. 1993).  
To take advantage of the wealth of available genomic information it is necessary to 
develop strategies to interrogate this resource in a meaningful and efficient manner to identify 
a subset or individual candidates that have an increased likelihood of displaying desirable 
properties. High throughput biochemical screening approaches can then be used to 
characterise as large a subset as possible. A search in November 2015 of the National Center 
for Biotechnology Information protein database with the search term ‘phytase’ revealed 
26,388 hits, of which 23,716 were from bacteria (Figure 1). A very small proportion of these 
hits have actually been characterised and tested to prove that they are indeed phytases and to 
determine their properties, the remainder are assigned as putative phytases using algorithms 
based on homology to known phytase sequences. One tool for annotation and assigning 
function is the Clusters of Orthologous Groups of proteins (COGs) database. This database is 
focused on microbial proteins and was established in 1997 (Tatusov et al. 1997) and most 
recently updated in 2014 (Galperin et al. 2015). It uses whole genome sequences to assign 
orthologues and paralogues and assigns function based on characterised protein family 
members. However, assigning function in terms of the reaction that is performed does not 
provide information on the suitability of the enzyme for the intended commercial 
applications. Knowing that a protein is likely to be a phytase does not provide any 
information regarding stability or the catalytic efficiency in gut conditions. With such a large 
number of putative sequences available, it is significantly challenging to identify and test 
candidate enzymes that could be suitable for commercial application. 
 
 
Figure 1 – Taxonomic group tree showing the origin of proteins labelled as phytase generated from the National 
Center for Biotechnology Information protein database (www.ncbi.nlm.nih.gov/protein) in November 
2015 with the number of proteins represented in each group shown in brackets. *Cytophaga-
Flavobacterium-Bacteroides group. Other sequences are Archaea (8), viruses (7) and others (219). 
 
Along with the rapid development of DNA sequencing technologies that has led to this large 
number of putative phytase sequences, the ability to ‘write’ DNA through gene synthesis and 
its ready commercial availability has made obtaining and testing sequences far easier and 
cheaper than ever before. Nevertheless the cost of gene synthesis is still in the order of 
US$0.20 per base pair at best meaning around US$200 per gene for a typical phytase gene of 
around 1000 base pairs. To access only 1% of the available sequences would cost around 
US$50,000. Even though the ability to readily purchase synthetic genes has already 
revolutionised molecular biology, for it to become a high throughput tool a reduction in cost 
of one or two orders of magnitude is required. This observation is not lost on a range of 
existing and emerging synthetic biology companies who are aiming to reduce the cost of 
writing DNA in a similar fashion to the dramatic cost reductions and increases in throughput 
observed with reading DNA (Kosuri and Church 2014). 
Regardless of the cost, to obtain only 1% of the available sequences, 263 phytases 
would still need to be produced and tested. This testing remains a considerable effort using 
traditional enzyme production methods to generate and culture recombinant microbes and 
biochemical assays to test the enzymes. Even 10% would be a serious undertaking. Efforts to 
increase the throughput of protein synthesis and testing include the use of in vitro or cell-free 
transcription and translation. This method avoids the bottleneck of generating production 
strains through plasmid cloning and microbial transformation with the DNA. For example, a 
system has been designed for high-throughput parallel cloning using species independent 
promoters for cell-free synthesis in lysates from a variety of organisms (Gagoski et al. 2015). 
In addition, as little as 0.1 ng of plasmid DNA was required for detectable protein synthesis, 
providing the prospect of future miniaturisation and subsequent increases in throughput. 
Given the cost of gene synthesis and an upper practical limit on the number of 
sequences that can be tested, it is currently necessary to be smart or lucky, or both, in the 
initial selection of candidate sequences as well as having an initial biochemical screening 
system that is as high throughput as possible. The use of in silico methods and bioinformatics 
tools could be used to interrogate the databases to produce a subset of sequences that are 
more likely to display desirable qualities (such as high stability and catalytic activity) 
compared to random selection. Such an approach was demonstrated successfully for the 
identification of (R)-transaminase enzymes. Enantio-preference was predicted through the 
rational design of mutated variants in related enzymes that may confer the desired specificity, 
followed by database searching to identify natural sequences already containing the predicted 
mutations (Höhne et al. 2010).  
Using in silico approaches to reliably predict protein stability and the effects of amino 
acid variation in similar sequences remains a significant challenge. These challenges arise 
partly from the complexity of protein structure and the way proteins stably fold as well as the 
dependence of stability on external conditions such as buffer composition (e.g. pH and salt 
concentration). Four methods for predicting stability were evaluated that were based on the 
Gibbs free energy of protein folding and the change in Gibbs free energy upon mutation at 
specific positions (Thiltgen and Goldstein 2012). Each method showed limitations, especially 
where the mutation was at a position buried within the protein structure. The Rosetta 
approach (Rohl et al. 2004) was overall as good as or better than the other three but it is not 
ideally suited for screening databases for the prediction of the most stable orthologue. 
Recognising these limitations, new methods for predicting the effect of mutations on protein 
stability continue to be generated but these are also not yet suitable for database screening 
and are often limited to single mutations per protein, for example with the programmes 
DUET (Pires et al. 2014) and PoPMuSiC (Dehouck et al. 2011). Overall these tools are 
designed for the analysis of point mutations in specific proteins or to aid protein engineering 
strategies to improve stability through mutation. Approaches for determining catalytic 
efficiency and selecting sequences likely to lead to high enzyme activity are even more 
challenging. These approaches have mainly been targeted at designing and predicting 
sequence modifications for enzyme improvement (Damborsky and Brezovsky 2014). Further 
developments and new approaches are required to be able to reliably select sub-populations 
of putative enzyme sequences from databases that have increased likelihood of commercially 
desirable levels of stability and activity. 
 
III. DEVELOPING EXISTING ENZYMES 
 
a) Commercial Examples 
 
The commonly used phytases in livestock production were developed using a variety 
of approaches, including enzyme isolation and biochemical characterisation coupled with 
recombinant expression. In addition, significant developments have been made to achieve 
economic levels of production in fermentations using a variety of recombinant 
microorganisms. Table 1 describes some examples of phytases that have been or are currently 
on the market, the list is not exhaustive and enzyme variants and manufacturing methods, 
including the production strain, are often updated and changed for various reasons. Also, 
although the donor organism is listed, a specific organism may have more than one phytase, 
such as the PhyA and PhyB phytases from Aspergillus niger (Ehrlich et al. 1993) with the 
Natuphos product derived from PhyA. Enzymes from certain donor organisms may also be 
modified through protein engineering to alter their sequences and therefore properties. As 
such, different products based on the same wild-type sequence, for example the E. coli 
phytase, will not necessarily all have the same performance.  
 
Table 1 – Examples of commercial phytase products. 
Company Trade 
Name 
Donor 
organism 
Production organism Reference 
BASF Natuphos Aspergillus 
niger 
Aspergillus niger (EFSA 2006a) 
DSM 
Nutritional 
Products 
RONOZY
ME P, NP 
Peniophora 
lycii 
Aspergillus oryzae (EFSA 2010) 
DSM 
Nutritional 
Products 
RONOZY
ME HiPhos 
Citrobacter 
braakii  
Aspergillus oryzae (Guggenbuhl et 
al. 2012) 
Adisseo Rovabio 
PHY 
Penicillium 
funiculosum 
Penicillium 
funiculosum 
(EFSA 2007) 
Danisco Animal 
Nutrition 
Phyzyme 
XP 
Escherichia 
coli 
Schizosaccharomyces 
pombe 
(EFSA 2006b, 
EUROPA 2007) 
Huvepharma OptiPhos Escherichia 
coli 
Pichia pastoris* (EFSA 2011) 
AB Enzymes Quantum Escherichia 
coli 
Pichia pastoris* (EFSA 2008) 
AB Vista Quantum 
Blue 
Escherichia 
coli 
Trichoderma reesei (EFSA 2013) 
 The donor organism refers to the organism from which the gene encoding the phytase was derived. 
* Now renamed as Komagaetella pastoris. 
 
In each case listed in Table 1, the production organism was genetically modified to 
generate suitably high levels of phytase, even where the production strain is listed as being 
the same as the donor organism. For example, for Rovabio PHY, the production organism is 
strain A1346 of P. funiculosum that was isolated from the soil and naturally produces three 
phosphatases, including a phytase, as well as beta-glucanase, xylanase and laminarinase. 
Strain A1346 was modified by mutagenesis and the gene encoding the phytase was isolated 
from this strain before being integrated onto the genome of the production strain A1346. An 
advantage of this approach is that the production organism was already known to produce and 
secrete this specific phytase. The disadvantage is that the strain had not previously been used 
for commercial production with associated data on safety and economic production and with 
no existing molecular biology tools for advanced genetic manipulations. In other cases, the 
gene encoding the phytase was transferred to an established protein production host such as 
P. pastoris that is well characterised, has genetic tools available and for which there are many 
examples of high yield production of a variety of recombinant proteins (Ahmad et al. 2014, 
Spohner et al. 2015). Using a well-characterised and understood expression host for which 
safe use is established and significant experience of industrial scale fermentations exist has 
clear advantages and each company will tend to favour their preferred production strains for 
this reason. A potential disadvantage is that not all genes and enzyme sequences are well 
matched to all production hosts due to issues with post-translational modification (such as 
disulfide bond formation and glycosylation) and secretory pathways for example. 
Nevertheless, unless there are significant issues, companies will tend to persist with their 
production organism of choice for operational reasons such as well-understood process 
engineering and the reduced risk of cross-contamination. 
Regardless of the inherent specific activity of each phytase, the number of units of 
enzyme activity per unit mass of product can be manipulated during the enzyme formulation 
stage using more dilute or concentrated formulations. Enzyme stability on the other hand 
cannot be manipulated in this way although the enzyme can be added at larger doses to 
compensate for losses. One key stage for enzyme deactivation is during the feed pelleting 
process (Table 2). Thus significant research efforts are directed at obtaining enzyme 
formulations where as much of the enzyme activity as possible survives. Increased stability 
can either be achieved through protein engineering or through modifying the formulation of 
the enzyme product. For example, the OptiPhos CT formulation was more stable than the G 
formulation (Table 2). Where pelleting stability data are provided in The EFSA Journal 
reports, this usually refers to solid formulations, with liquid formulations generally intended 
for post pelleting application to avoid deactivation. The availability of liquid formulations 
and the data in Table 2 both indicate that increased stability phytases, which also retain high 
levels of activity at gut temperature, are still needed. 
 
Table 2 – Pelleting stability of commercial phytase products. 
Trade Name Formulation Pelleting 
Temp. (ºC) 
Minimum residual 
activity (%) 
Reference 
RONOZYME 
P 
Solid 70 
80 
90 
100 
86 
80 
(EFSA 2010) 
Phyzyme XP Solid, 5000G∆ 80 82 (EFSA 2006c) 
OptiPhos Solid, G  
 
 
Solid, CT* 
65 
75 
85 
65 
75 
85 
77 
78 
48 
83 
89 
85 
(EFSA 2011) 
Quantum Solid 80 
90 
87.5 
70 
(EFSA 2008) 
∆ Formulated with wheat flour with calcium propionate and citric acid preservatives. 
 Formulated with 23% solid enzyme concentrate, 1% pre-gelatinised starch and wheat flour. 
* Formulated with 30% solid enzyme concentrate, 1% pre-gelatinised starch, 13.5% monoglyceride, 13.5% palm 
oil, up to 20% corn grits and wheat flour. 
 
In addition to pelleting stability, product registration documents also outline storage 
stability at various temperatures (normally up to 40 ºC) over several months. Typically, 
enzyme preparations are stable at lower temperatures but many products lose significant 
activity if stored at or above 35 ºC.  
Overall, the wide variety of testing methods and assay conditions used makes a direct 
comparison of enzyme properties reported in the literature problematic and interpretations 
should be treated with caution. A recent study however directly compared Ronozyme HiPhos, 
Ronozyme NP, as well as an E. coli and an A. niger phytase from Chinese suppliers to an A. 
niger phytase produced by the authors (Nielsen et al. 2015). The authors showed that 
Ronozyme NP (an optimised P. lycii phytase) was the most thermostable, followed by 
Ronozyme HiPhos. These enzymes however were the least stable in simulated gastric 
conditions of pH 2 in the presence of the protease pepsin. The authors also discussed the 
consistency of their results with previous studies, such as for pepsin resistance or pH stability 
(Igbasan et al. 2000), where different enzyme variants or changes in conditions (such as pH) 
may have been used and again concluded that the interpretation of results should be treated 
with caution. Whilst lab simulations of activity can be very useful guides to enzyme 
performance the only way to fully test efficacy is through enzyme formulation in feed pellets 
and subsequent feeding trials.  
 
b) Optimising the E. coli phytase 
 
There have been many attempts to improve the properties of the E. coli AppA phytase 
through mutagenesis. In a prominent example, scientists at Diversa Corporation (later 
Verenium and now part of BASF) produced an enzyme that was mutated at eight different 
amino acid positions to achieve increased thermostability (Garrett et al. 2004, Short et al. 
2008). Mutagenesis of amino acids at each position in the protein sequence to every other 
amino acid (saturation mutagenesis) coupled with screening identified a range of beneficial 
mutations. These were then combined to produce a protein termed Phy9X that is also referred 
to as NOV9X in the patent literature (Lanahan et al. 2006) and Quantum phytase registration 
documents (EFSA 2008). Differential scanning colorimetry showed that the melting 
temperature was increased by 12 ºC to 75.7 ºC with a 3.5-fold increase in stability in 
simulated gastric fluid.  
Recently, two additional mutations were added to Phy9X (Q258N and Q349N – note 
the numbering starts at different places in the protein between different papers) to introduce 
additional N-glycosylation sites when expressed in P. pastoris (Wang et al. 2015). These 
mutations resulted in an observed increase in melting temperature of 7.5 ºC compared to the 
wild-type enzyme, attributable to increases in α-helix content and surface hydrophobicity. 
Increasing thermal stability through the incorporation of additional disulfide bonds is 
another common strategy in protein engineering and the basis of this effect has been 
examined using a range of phytases including that from C. braakii (Sanchez-Romero et al. 
2013). The native E. coli phytase has four disulfide bonds and including three additional 
disulfide bonds increased the melting temperature by 8.5 ºC and shifted the optimal 
temperature for activity to 75 ºC (De Maria et al. 2013). 
 
IV. CONCLUSIONS 
 
There has been significant work over recent decades on the development and production of 
phytases for livestock feed applications. These enzymes have resulted in commercial 
products with significant benefits for producers. With the recent rapid advances in DNA 
sequencing technology, the availability of genomic data and the ready access to synthetic 
biology tools there exists an opportunity to develop phytases with further improved 
characteristics if these data and tools can be effectively harnessed. 
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